Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AEterna Zentaris Inc (NASDAQ:AEZS)

2.94
Delayed Data
As of Feb 09
 -0.06 / -2.00%
Today’s Change
2.60
Today|||52-Week Range
88.90
-34.38%
Year-to-Date
No recent news for AEterna Zentaris Inc.

Today’s Trading

Previous close3.00
Today’s open3.00
Day’s range2.87 - 3.01
Volume135,688
Average volume (3 months)1,403,458
Market cap$29.2M
Dividend yield--
Data as of 02/09/2016

Growth & Valuation

Earnings growth (last year)-221.74%
Earnings growth (this year)+93.22%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)-99.82%
P/E ratio--
Price/Sales3,196.60
Price/Book0.13

Competitors

 Today’s
change
Today’s
% change
OPGNOpGen Inc-0.20-11.63%
ABACAoxin Tianli Group I...+0.13+20.31%
IMUCImmunoCellular Thera...-0.00-1.51%
PBMDPrima BioMed Ltd-0.04-4.44%
Data as of 02/09/2016

Financials

Next reporting dateMarch 22, 2016
EPS forecast (this quarter)-$1.29
Annual revenue (last year)$11.0K
Annual profit (last year)-$16.6M
Net profit margin-156,245.45%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
David A. Dodd
Chief Financial &
Accounting Officer, VP-Finance
Keith Santorelli
Corporate headquarters
Québec, Qubec

Forecasts

Partner Offers